Cardiac device maker Heart Test seeking to raise $10M through IPO

Key Facts

• Heart Test didn’t disclose terms in its filing, but indicated in its filing fee form that it was looking to raise up to $10M through the sale of an undisclosed number of units, with each unit consisting of one share and one warrant to buy one share.
• The medtech company intends to list its shares on Nasdaq under the symbol HSCS.
• The company plans to use proceeds from the IPO in part to win FDA clearance for the product.
• The company is still operating in the red.

Click To Read Full Article